Daiva Masanauskaite

Intravenous ibandronate injections in postmenopausal women with osteoporosis: One‐year results from the dosing intravenous administration study

Pierre D. Delmas, Silvano Adami, Cezary Strugała et al. · Arthritis & Rheumatism · 2006 · 258 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)

Ronald Emkey, William Koltun, Kathleen Beusterien et al. · Current Medical Research and Opinion · 2005 · 171 citations

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.

John A. Eisman, Roberto Civitelli, Silvano Adami et al. · PubMed · 2008 · 161 citations

Medicine, Endocrinology, Pharmacotherapy +16

Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II)

Peyman Hadji, H. W. Minne, Michael Pfeifer et al. · Joint Bone Spine · 2008 · 64 citations

Medicine, Endocrinology, Pharmacotherapy +12

Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study

Paul D. Miller, Robert R. Recker, J.-Y. Reginster et al. · Osteoporosis International · 2011 · 60 citations

Pharmacy, Pharmacotherapy, Oral Medicine In Older Adults +1